In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
2DG has been given emergency approval by the Drug Controller General of India for COVID-19 patients in the country
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
The GMP certificate is valid for three years until April 2024.
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Subscribe To Our Newsletter & Stay Updated
